BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/19/2024 10:25:00 AM | Browse: 119 | Download: 570
 |
Received |
|
2024-03-03 22:10 |
|
Peer-Review Started |
|
2024-03-03 22:10 |
|
First Decision by Editorial Office Director |
|
2024-04-11 04:06 |
|
Return for Revision |
|
2024-04-11 04:06 |
|
Revised |
|
2024-04-22 11:11 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-05-15 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-05-15 06:25 |
|
Articles in Press |
|
2024-05-15 06:25 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-11 01:11 |
|
Publish the Manuscript Online |
|
2024-06-19 10:25 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Management of male obesity-related secondary hypogonadism: A clinical update
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohan T Shenoy, Sunetra Mondal, Cornelius James Fernandez and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, Academic Editor, Consultant Physician-Scientist, Professor, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Sharoe Green Lane , Preston PR2 9HT, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Male obesity-related secondary hypogonadism; Androgen therapy; Testosterone replacement therapy; Obesity; Cardiovascular benefits |
| Core Tip |
The obesity pandemic has increased the prevalence of obesity-related health morbidities including male obesity-related secondary hypogonadism (MOSH). Although weight loss is the ideal therapeutic option for MOSH, testosterone replacement therapy (TRT) is often necessary because of the difficulty in achieving significant weight loss through lifestyle interventions or pharmacotherapy which might also improve obesity-related comorbidities. TRT should be coupled with the management of other comorbidities related to obesity in MOSH patients to optimize management which is updated in this evidence-based review. |
| Publish Date |
2024-06-19 10:25 |
| Citation |
Shenoy MT, Mondal S, Fernandez CJ, Pappachan JM. Management of male obesity-related secondary hypogonadism: A clinical update. World J Exp Med 2024; 14(2): 93689 |
| URL |
https://www.wjgnet.com/2220-315x/full/v14/i2/93689.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v14.i2.93689 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
